Truqap

Active Ingredient(s): Capivasertib
FDA Approved: * November 16, 2023
Pharm Company: * ASTRAZENECA PHARMS
Category: Cancer
* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Truqap 160 mg Oral Tablet, Film Coated
NDC: 0310-9500
Labeler:
Astrazeneca Pharmaceuticals Lp
Truqap 200 mg Oral Tablet, Film Coated
NDC: 0310-9501
Labeler:
Astrazeneca Pharmaceuticals Lp